======= ST6GALNAC6 ======= == Gene Information == * **Official Symbol**: ST6GALNAC6 * **Official Name**: ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30815|30815]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q969X2|Q969X2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ST6GALNAC6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ST6GALNAC6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610135|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Alpha-2,6-sialyltransferase involved in the synthesis of alpha-series gangliosides. Has activity toward GD1a, GT1b and GM1b. Has no activity toward glycoproteins. Responsible for the biosynthesis of DSGG (disialylgalactosylgloboside) from MSGG (monosialylgalactosylgloboside) in normal and malignant kidney. Participates in the synthesis of disialyl Lewis a (Le(a)). {ECO:0000269|PubMed:12668675, ECO:0000269|PubMed:17123352}. |Glyco transf 29| |alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity| |ganglioside biosynthetic process| |sialyltransferase activity| |glycosylceramide metabolic process| |oligosaccharide biosynthetic process| |ganglioside metabolic process| |sialylation| |glycosphingolipid biosynthetic process| |ceramide biosynthetic process| |oligosaccharide metabolic process| |glycosphingolipid metabolic process| |glycolipid biosynthetic process| |cell-cell recognition| |ceramide metabolic process| |sphingolipid biosynthetic process| |glycolipid metabolic process| |liposaccharide metabolic process| |carbohydrate biosynthetic process| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |membrane lipid metabolic process| |cell recognition| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |amide biosynthetic process| |lipid biosynthetic process| |Golgi membrane| |carbohydrate derivative biosynthetic process| |cellular amide metabolic process| |cellular lipid metabolic process| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp376|Losmapimod 1μM R07 exp376]]|-2.21| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12801 * **Expression level (log2 read counts)**: 5.29 {{:chemogenomics:nalm6 dist.png?nolink |}}